Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2008-09-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SJM MRI Diagnostic Imaging Registry (IDE)
NCT02807948
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
NCT05643235
Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
NCT03720639
Validation of CardioMEMS HF System Cardiac Output Algorithm IDE
NCT05428384
DEtermining Accuracy and TrEnding CharacTerization of AF
NCT01673256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Label
SJM Confirm Device
SJM Confirm
All patients in this study will receive the SJM Confirm device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SJM Confirm
All patients in this study will receive the SJM Confirm device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who experience transient symptoms that may suggest a cardiac arrhythmia
* Patients who have been previously diagnosed with atrial fibrillation
* Patients who are suspected to have Atrial Fibrillation (AF) but AF has not been documented
* Patients who have provided written informed consent to participate in the study.
Exclusion Criteria
* Patients who have a life expectancy less than 1 year
* Patients who are unable to comply with the follow-up schedule
* Patients who are currently implanted with a pacemaker or defibrillator
* Patients who the physician deems inappropriate for the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Shipman
Role: STUDY_DIRECTOR
Abbott Medical Devices
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaska Heart Institute
Anchorage, Alaska, United States
Arizona Arrhythmia Research
Scottsdale, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
St. Jude Hospital
Fullerton, California, United States
Scripps Clinic
La Jolla, California, United States
Oklahoma Heart Institute at Utica
Tulsa, Oklahoma, United States
Providence- St Vincent Medical Center
Portland, Oregon, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
University of Virginia
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
60020941D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.